SAGE Therapeutics

Sage, Biogen post fresh phase 3 depression data as FDA filing nears completion
Fierce Biotech
Mon, 10/17/22 - 10:39 am
SAGE Therapeutics
Biogen
zuranolone
postpartum depression
clinical trials
Ahead of FDA filing, Sage and Biogen tout more data in hopes of alleviating durability concerns
Endpoints
Mon, 09/19/22 - 09:53 pm
SAGE Therapeutics
Biogen
major depressive disorder
zuranolone
Chasing Sage, PureTech’s oral depression drug clears early bioavailability test
Fierce Pharma
Tue, 06/14/22 - 09:09 pm
PureTech Health
SAGE Therapeutics
allopregnanolone
clinical trials
clinical depression
Sage, Biogen drug meets goal in postpartum depression study
BioPharma Dive
Wed, 06/1/22 - 07:32 pm
SAGE Therapeutics
Biogen
FDA
zuranolone
postpartum depression
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Pfizer
Biohaven
licensing
M&A
Aurinia
Bristol Myers Squibb
AbbVie
Alector
Arcus Biosciences
Biogen
Blueprint Medicines
CureVac
Gilead Sciences
GSK
Incyte
MorphoSys
Roche
Nestle
SAGE Therapeutics
Sarepta Therapeutics
Seres Therapeutics
Syndax
Sage, Biogen get rolling on FDA submission for depression med
Fierce Biotech
Mon, 05/2/22 - 11:52 am
SAGE Therapeutics
Biogen
zuranolone
FDA
major depressive disorder
Sage's phase 2 Alzheimer's drug shows signs of cognitive improvement—but there's a catch
Fierce Biotech
Fri, 04/1/22 - 10:47 am
SAGE Therapeutics
SAGE-718
Alzheimer's disease
clinical trials
Significant readouts for small players
EP Vantage
Thu, 03/31/22 - 10:22 am
clinical trials
SAGE Therapeutics
Biogen
Relmada
Athira Pharma
TauRx
Sage claims new data show depression drug works, but doubts remain
Biopharma Dive
Wed, 02/16/22 - 11:05 pm
SAGE Therapeutics
Biogen
depression
clinical trials
zuranolone
Sage changes primary endpoint in key study months after analysts fret about depression drug's durability
Endpoints
Wed, 11/3/21 - 10:41 am
SAGE Therapeutics
clinical trials
zuranolone
depression
endpoints
SSRIs
Biogen, Sage plot 2022 filing for zuranolone approval, furthering turnaround of depression drug
Fierce Biotech
Tue, 10/19/21 - 11:54 am
Biogen
SAGE Therapeutics
zuranolone
FDA
clinical depression
Biogen and Sage Present Positive Data for Breakthrough Depression Therapy
BioSpace
Mon, 10/4/21 - 10:55 pm
Biogen
SAGE Therapeutics
major depressive disorder
postpartum depression
clinical trials
zuranolone
Late-Stage Clinical Study Readouts Biotech Investors Should Watch
Motley Fool
Sun, 07/11/21 - 11:13 pm
clinical trials
Novartis
Biogen
SAGE Therapeutics
uniQure
Pfizer
Roche
Sage Therapeutics Plunges After Depression Drug-Trial Results
TheStreet.com
Tue, 06/15/21 - 10:36 am
SAGE Therapeutics
clinical trials
depression
Biogen
zuranolone
Sage braces for make-or-break depression data
BioPharma Dive
Tue, 05/4/21 - 10:41 pm
SAGE Therapeutics
earnings
major depressive disorder
Zulresso
Sage, Biogen's tremor drug hits goal, but 38% of people drop out
Fierce Biotech
Mon, 04/12/21 - 10:36 am
SAGE Therapeutics
Biogen
essential tremor
SAGE-324
side effects
clinical trials
A busy year ahead for Parkinson’s disease
EP Vantage
Wed, 03/3/21 - 10:56 am
Parkinson's Disease
drug development
AstraZeneca
Roche
Prothena
MeiraGTx
Annovis Bio
Sanofi
Alkahest
Peptron
SAGE Therapeutics
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
Sun, 01/17/21 - 05:01 pm
clinical trials
Novavax
AstraZeneca
JNJ
vaccines
COVID-19
Biomarin
Amgen
Merck
Pfizer
Roche
SAGE Therapeutics
Biogen
Vertex Pharmaceuticals
A Bright Day for Two Companies as New CEOs Announced
BioSpace
Thu, 12/17/20 - 11:08 am
Pharma CEOs
SAGE Therapeutics
Samsung BioLogics
Is Biogen Getting Desperate?
Motley Fool
Wed, 12/9/20 - 10:42 am
Biogen
SAGE Therapeutics
major depressive disorder
depression

Pages